Monitoring impurities in biopharmaceuticals produced by recombinant technology

被引:22
作者
DiPaolo, B [1 ]
Pennetti, A [1 ]
Nugent, L [1 ]
Venkat, K [1 ]
机构
[1] SmithKline Beecham, Analyt Serv, King Of Prussia, PA 19406 USA
来源
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY | 1999年 / 2卷 / 02期
关键词
D O I
10.1016/S1461-5347(99)00120-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The unique nature of recombinant: technology and the biotherapeutic production process means that regulatory agencies around the world not only require extensive characterization of the product, but they have also provided 'guidelines' to control and monitor product- and process-derived impurities and contaminants, Not only might these impurities and contaminants have a profound effect on product quality and efficacy, but they might also introduce unwanted and unknown side effects, even in trace amounts. The authors present a comprehensive understanding of the nature of possible product- and process-related impurities, and also describe current and future methodologies to control and monitor these impurities.
引用
收藏
页码:70 / 82
页数:13
相关论文
共 99 条
[61]  
MARTIN R, 1990, BIOTECHNIQUES, V9, P762
[62]   Sensitive high-resolution analysis of biological molecules by capillary zone electrophoresis coupled with reflecting time-of-flight mass spectrometry [J].
McComb, ME ;
Krutchinsky, AN ;
Ens, W ;
Standing, KG ;
Perreault, H .
JOURNAL OF CHROMATOGRAPHY A, 1998, 800 (01) :1-11
[63]  
Mukhopadhyay A, 1997, Adv Biochem Eng Biotechnol, V56, P61
[64]   COMPARISON OF A NEW HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY METHOD WITH FLUORESCENCE POLARIZATION IMMUNOASSAY FOR ANALYSIS OF METHOTREXATE [J].
NAJJAR, TAO ;
MATAR, KM ;
ALFAWAZ, IM .
THERAPEUTIC DRUG MONITORING, 1992, 14 (02) :142-146
[65]  
NARDELLA FA, 1988, SCAND J RHEUMATOL S, V75, P19
[66]  
NGUYEN TH, 1994, ACS SYM SER, V567, P59
[67]  
NUGENT LF, 1998, 2 S AN WELL CHAR BIO
[68]   CLINICAL-EVALUATION OF THE ABBOTT TDX FLUORESCENCE POLARIZATION IMMUNOASSAY ANALYZER [J].
OELTGEN, PR ;
SHANK, WA ;
BLOUIN, RA ;
CLARK, T .
THERAPEUTIC DRUG MONITORING, 1984, 6 (03) :360-367
[69]   Separation of biologically active peptides by capillary electrophoresis and high-performance liquid chromatography [J].
Pacakova, V ;
Suchankova, J ;
Stulik, K .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 681 (01) :69-76
[70]  
PENNETTI A, 1998, 2 S AN WELL CHAR BIO